--- title: "12 Health Care Stocks Moving In Monday's Pre-Market Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/281018182.md" description: "In Monday's pre-market session, Iterum Therapeutics (ITRM) shares surged 113.5% to $0.08, while Bullfrog AI Hldgs (BFRG) rose 94.78% to $0.99. Other gainers included Aprea Therapeutics (APRE) up 22.98% to $0.84, ProQR Therapeutics (PRQR) up 20.43% to $1.65, and United Therapeutics (UTHR) up 14.76% to $600. Conversely, Viridian Therapeutics (VRDN) fell 36.5% to $17.39, Artelo Biosciences (ARTL) dropped 28.28% to $7.56, and ImageneBio (IMA) decreased 20.0% to $4.00." datetime: "2026-03-30T12:05:41.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/281018182.md) - [en](https://longbridge.com/en/news/281018182.md) - [zh-HK](https://longbridge.com/zh-HK/news/281018182.md) --- # 12 Health Care Stocks Moving In Monday's Pre-Market Session ### Gainers - **Iterum Therapeutics** (NASDAQ:ITRM) shares rose 113.5% to $0.08 during Monday's pre-market session. The market value of their outstanding shares is at $1.8 million. - **Bullfrog AI Hldgs** (NASDAQ:BFRG) shares moved upwards by 94.78% to $0.99. The company's market cap stands at $6.4 million. - **Aprea Therapeutics** (NASDAQ:APRE) shares moved upwards by 22.98% to $0.84. The market value of their outstanding shares is at $7.8 million. - **ProQR Therapeutics** (NASDAQ:PRQR) stock moved upwards by 20.43% to $1.65. The market value of their outstanding shares is at $145.0 million. - **United Therapeutics** (NASDAQ:UTHR) stock increased by 14.76% to $600.0. The market value of their outstanding shares is at $22.5 billion. - **Quantum BioPharma** (NASDAQ:QNTM) shares moved upwards by 12.88% to $5.38. The company's market cap stands at $20.0 million. As per the news, the Q4 earnings report came out 2 days ago. ### Losers - **Viridian Therapeutics** (NASDAQ:VRDN) stock declined by 36.5% to $17.39 during Monday's pre-market session. The market value of their outstanding shares is at $2.6 billion. - **Artelo Biosciences** (NASDAQ:ARTL) stock declined by 28.28% to $7.56. The company's market cap stands at $7.7 million. - **ImageneBio** (NASDAQ:IMA) stock fell 20.0% to $4.0. The market value of their outstanding shares is at $55.9 million. - **Onconetix** (NASDAQ:ONCO) shares decreased by 18.05% to $1.59. The market value of their outstanding shares is at $1.3 million. - **Cuprina Holdings (Cayman)** (NASDAQ:CUPR) shares declined by 17.31% to $0.33. The company's market cap stands at $2.9 million. - **Agape ATP** (NASDAQ:ATPC) shares fell 17.19% to $2.65. The company's market cap stands at $3.2 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [PRQR.US](https://longbridge.com/en/quote/PRQR.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [BFRG.US](https://longbridge.com/en/quote/BFRG.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [ITRM.US](https://longbridge.com/en/quote/ITRM.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [APRE.US](https://longbridge.com/en/quote/APRE.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [UTHR.US](https://longbridge.com/en/quote/UTHR.US.md) - [ARTL.US](https://longbridge.com/en/quote/ARTL.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [IMA.US](https://longbridge.com/en/quote/IMA.US.md) - [ITRMF.US](https://longbridge.com/en/quote/ITRMF.US.md) ## Related News & Research - [ProQR Q2 revenue more than doubles](https://longbridge.com/en/news/295787634.md) - [Artelo Biosciences Q2 net loss narrows as R&D expenses fall](https://longbridge.com/en/news/295796619.md) - [United Therapeutics (NASDAQ:UTHR) CEO Sells 9,500 Shares](https://longbridge.com/en/news/295639080.md) - [United Therapeutics CEO Martine Rothblatt disposes of 9,500 shares for $4.79 million](https://longbridge.com/en/news/296267380.md) - [United Therapeutics seeks FDA priority review for Tyvaso label expansion in IPF](https://longbridge.com/en/news/296094667.md)